Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript

Sep 23, 2020 / 02:30PM GMT
Release Date Price: $51.69
Wimal Kapadia
Sanford C. Bernstein & Co., LLC., Research Division - Research Analyst

Excellent. So good afternoon, everybody, and thank you for joining. I am Wimal Kapadia, the EU biopharma analyst here at Bernstein. It's my great pleasure to introduce Paul Hudson, CEO of Sanofi; and Jean-Baptiste de Chatillon, CFO of Sanofi.

So thank you both for joining today. I know it's been a very busy month for conferences within health care. So I really appreciate your time in your busy schedules.

So before we start, I'll just deliver housekeeping, I would like to remind investors that they are able to submit questions through the joint live Q&A link available to the left-hand side of your viewing screen. I will try and incorporate these questions as we move through the discussion. So please do participate, and it's nice to see several questions already posted online. So thank you very much for that. You can also provide feedback through the share and view investor sentiment link, which have immediate access to the poll results. If you do, the link will also appear at the conclusion of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot